Tempted by Low Rates, Pfizer Returns To Term Market After a 10-Year Hiatus
Attractive interest rates lured Pfizer Inc. back to the term debt market with a $250 million offering after a 10-year absence.
Access to authoritative analysis and perspective and our data-driven report series.
14-Day Free Trial
No credit card required. Complete access to articles, breaking news and industry data.
Have an account? Sign In